Agoracom Blog Home

Archive for the ‘Featured’ Category

« Older Entries
Newer Entries »

Companies like Imagine AR $IP.ca are already ahead of the curve in offering mobile based AR experiences, states #CNBC $SEV.ca $VST.ca $YDX.ca

Posted by AGORACOM-JC at 7:39 PM on Sunday, April 26th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • CNBC Article mentions “Companies like Imagine AR (formerly Imagination Park Technologies Inc.) are already ahead of the curve in offering mobile based AR experiences, partnering with teams like the Sacramento Kings to create future AR offerings.“
  •  “Those are the technologies that have to be invested in and expanded by [teams] because they’ve got to fill the void for [lost attendance],” Miller said.

By: Jabari Young & Megan Graham

With games suspended, sports leagues will not only need to refund consumers, but also prepare for the future of sports ticketing due to the economic impact caused by Covid-19.

  • U.S. leagues have been on pause since March 11, when the NBA became the first to suspend games due to the coronavirus pandemic.
  • There is a bubble on the verge of bursting throughout sports leagues, adding to the already mounting problems facing an industry currently on pause due to the coronavirus pandemic. While leagues like the NBA, MLB and NHL have all suspended their seasons, a big bill could come due if they’re forced to outright cancel games, triggering a flood of calls from ticket holders for refunds. “It’s going be like what the airline and cruise lines are going through,” longtime sports exec Dr. Harvey Schiller told CNBC in an interview. “They are going have to come up with some general refund policy depending on the league.” The coronavirus is especially hurting the NBA and NHL, which are usually busy around this time as they gear up for playoff games and woo season ticket holders about renewal options for the next season. Clubs also lose the ability to continue tracking data from fans’ in-stadium spending habits and game day routines in an age of creating more personalized experiences in arenas. In a various conversations with team executives, who spoke to CNBC on condition of anonymity, some clubs have already refunded fans who requested it, while other teams are offering discounted prices for ticket packages once fans are allowed back.  But teams will not be able to retain fans’ money too much longer. With unemployment skyrocketing, affecting more than 20 million people within the last month, more consumers will demand refunds, setting off phase one of what some in the sports industry said will be a period of revamping ticket monetization concepts after the pandemic is over. Schiller said teams would need to “get creative,” especially during a period of fan-free arenas, at least until new safety protocols are established and a coronavirus vaccine or treatment becomes available. And even when fans are allowed back in arenas, clubs won’t be able to offer ticket packages with just merchandise, food and beverage items included. Concepts for sporting events will have to change for a new generation of fans, while still retaining established customers. Suffering at the gate Schiller, the former president of the defunct NHL franchise, the Atlanta Thrashers, said it’s not unusual for teams to take out loans and use projected ticket sales as collateral, as clubs need funding to sustain operations throughout the year. More than likely, he said, those loans aren’t in jeopardy, as banks know sports teams are good for repaying. But until fans are allowed back in, organizations will need to find a way to make up game day dollars, which accounts for a substantial percentage of yearly revenue. According to one of the sports execs, the average gate receipt for a non-playoff NBA game is roughly $1 to $1.5 million. Last month, NBC Sports estimated the league could lose $500 million in ticket revenue when factoring in postseason games. According to a outlook report by accounting firm PricewaterhouseCoopers (PwC), gate revenue for the North American sports market grossed $19.2 billion in 2018, and is projected to increase to $21.8 billion in 2023. Marty Conway, a longtimesports marketing exec who developed digital and business strategies for organizations like AOL and the MLB’s Baltimore Orioles said he last estimated ticket revenue makes up roughly 36% of the NHL’s annual revenue, 30% of MLB’s and 22% of the NBA’s.  Conway, an adjunct professor at Georgetown University’s McDonough School of Business, said the NBA and NHL are attempting to return not only for media dollars but “additional postseason ticketing revenues.” “Gate receipts are important; that’s real money,” added former CBS Sports president Neal Pilson, who predicted a limited return to sports this summer with so much still unknown about Covid-19. Ticketing 2.0 With ticket revenue at risk, team execs are already contemplating what the future of their sport will look like in a world with no or a limited number of fans at games, at least in the short-term. Many teams have added a variety of subscription packages to attract younger fans and those who avoid buying full-season packages, but that model needs another upgrade in the post-coronavirus world. Chris McGowan the CEO of Vulcan Sports and Entertainment, the company started by late Microsoft co-founder Paul Allen, said his team the Portland Trailblazers will  “use this opportunity to look at every aspect of our entire operation.”  “What are areas we need to improve, areas we need to change?” McGowan said. “We are having lots conversations about that.” McGowan added that “technology is going to be a big factor” in new ticket offerings.  Mark Miller is the CEO of TicketSocket, a Newport Beach, California company that specializes in white labeling ticket solutions. Asked what new methods teams can adopt to help preserve ticket income, Miller suggested leagues get innovative about selling “single seats digitally” via virtual reality. The VR concept is one both the NBA and NHL has experimented with for several years, as the leagues seek to provide a better experience for at-home viewers. In 2019, the NHL partnered with tech company NextVR and Disney to enhance the VR experience, aiming to bring fans “closer to the on-ice action” and “make them feel like they are at a live NHL game,” according to a statement by Chris Golier, NHL vice president of business development. And in 2017, the MLB partnered with Intel to launch its VR experience. Leagues will need to enhance their platforms in hopes to entice customers, and now could be the opportunity leagues to invest in more augmented reality (AR) and VR experiences, a market projected to reach over $100 billion by 2025.  Companies like Imagination Park Technologies Inc. are already ahead of the curve in offering mobile based AR experiences, partnering with teams like the Sacramento Kings to create future AR offerings.  “Those are the technologies that have to be invested in and expanded by [teams] because they’ve got to fill the void for [lost attendance],” Miller said. Don White, the CEO of Satisfi Labs, an artificial intelligence management platform company, said tech firms are already studying “how to make your couch into this real premiere event until we can get back live audiences.”  “It’s an expansion as opposed to a transition,”  White said. “Ticketing is an important concept. I don’t think we should get away from ticketing in general because the ticket will also be your paid access. I think for sports, it’s important the ticket stays in the system.” The loss of on-site advertising dollars will also be an issue for some clubs. McGowan said the Blazers hadn’t experienced any significant pullback from ad partners with games on hold, but the team is in daily communication with companies as financial circumstances change. But even though companies are honoring partnerships, the structure of those agreements could look different .
  • Sports marketing post-Covid  IEG, a consultancy that’s owned by Bruin Sports Capital, last week released a study estimating that $10 billion in sponsorship value in the U.S. could be disrupted by the sports and entertainment shutdown, with 20,000 sports and entertainment properties affected. The group said more than 5,000 brands are working through how to make up that value, while 120,000 active sponsorships have been impacted. The survey found that 62% of sponsors are re-evaluating their plans, while 20% are decreasing spending and 15% aren’t making changes yet.  David Aburtyn, a partner at Bruin, said this doesn’t mean that $10 billion is lost, but that some new business could certainly be lost. Going forward, he said brands are thinking about how to do things in new, different ways. “That’s an area ripe for creativity and innovation,” Aburtyn said. One certainty we’ll see: Different timelines in the sponsorship world. Typically, sponsorships are planned far out, but some brands right now are thinking about what they can do in the much nearer-term, Aburtyn said. But fan-less events has an impact for sponsors, many of whom use sporting events to bring clients or prospects. “You don’t have an ability to host people and give them experiences — that stuff is very valuable as a sponsor,” said Dan Parise, SVP and managing director for Scout Sports & Entertainment, a division of Horizon Media. Parise said he hasn’t had any conversations about replicating that, say, with a video call with a client or prospect aligning with the event.  “There’s a little bit lost on the impact of face-to-face,” when communicating via video instead of in-person, he said.  Right now with so much uncertainty about the months ahead, the tenor of business seems to have cooled. Scout’s Parise said there doesn’t appear to be an overwhelming desire to buy sponsorships right now. And existing sponsors are thinking through a litany of contingencies.  “I think existing sponsors are trying to think about the various contingencies that they could have — if baseball happens in this way, how do I shift my activation strategy? If it happens with fans, without fans?” Parise said. Potential sponsors might also be struggling themselves.  “There are a lot of businesses that are hurting,” Parise said. “It’s harder for the sales folks to be out there pounding the pavement to find new sponsors; they don’t want to be seen as insensitive during this time.”  So much is in flux, but fanless sports might throw the financials of the whole sports ticketing and marketing world off kilter.  “The economics are so cranked up, and they’re cranked up because of media advertising and gate receipts,” said Dave Morgan, founder and CEO of Simulmedia and longtime media industry executive. “If you take away the gate receipts, media advertising can’t spend more, and media advertising depends a lot on a physical venue and a physical integration with the fans. So I would say, sports without fans takes a huge part of the value component that makes the economics work. And the question will be, out of whose pocket will this come?” Source: https://www.cnbc.com/2020/04/24/sports-ticketing-will-look-different-as-teams-get-creative-without-fans.html?utm_content=127744186&utm_medium=social&utm_source=linkedin&hss_channel=lcp-10871904

Tags: , , , , , , ,
Posted in Featured, Imagine AR | Comments Off on Companies like Imagine AR $IP.ca are already ahead of the curve in offering mobile based AR experiences, states #CNBC $SEV.ca $VST.ca $YDX.ca

Hollister Biosciences $HOLL.ca Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc. $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:20 AM on Thursday, April 23rd, 2020
  • Entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. and the shareholders of TargetCo
  • Alphamind Brands is developing a portfolio of certified legal mushroom based natural health products
  • The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.

VANCOUVER, April 23, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that it has entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. (“TargetCo“) and the shareholders of TargetCo (the “Definitive Agreement“), pursuant to which, the Company will acquire all of the issued and outstanding shares of TargetCo (the “Proposed Transaction“).  

Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments.  The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate. 

“We are very pleased to have completed the next step in consummating this very exciting acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc.  “It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous.  Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering.”

“I think we have found a great partner in Hollister”, shared Robert Birmingham, CEO of Alphamind Brands.  “We have medicinal mushroom based product SKU’s ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business.”

The Proposed Transaction

Pursuant to the terms of the Definitive Agreement, Hollister will acquire all of the issued and outstanding securities of TargetCo in consideration for the issuance of 6,000,000 common shares of the Company (the “Payment Shares“) pro rata to shareholders of TargetCo at a deemed price of $0.20 per Payment Share upon closing of the Proposed Transaction (the “Closing Date“).

The Proposed Transaction remains subject to certain closing conditions including, without limitation, (a) the receipt by Hollister of any necessary corporate and regulatory approval; and (b) each party’s representations and warranties in the Definitive Agreement being true and correct in all aspects as of the Closing Date, and each party meeting its terms and conditions and completing its covenants and obligations as contained therein. There can be no guarantees that the Proposed Transaction will be completed as contemplated or at all.

Hollister will not be assuming any long-term debt; no new control position will be created and there is no change in management or the Board of Directors of Hollister in connection with the Proposed Transaction.

In addition, the Company also reports that it will issue 500,000 common shares at a deemed price of $0.12 per share to an arm’s length consultant pursuant to a consulting agreement in which services were provided from December 1, 2019 to the date hereof.  In addition, the Company will issue 90,400 shares to an arm’s length consultant pursuant to a consulting agreement in which services have been rendered since February 17, 2020 (See press release dated February 25th, 2020).  All shares issued pursuant to the consulting agreements will be subject to a four month and a day hold period from the date of issuance.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

“Carl Saling”

CEO and Director

The CSE does not accept responsibility for the adequacy or accuracy of this release.

The CSE has not in any way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this press release.

The securities to be issued in connection with the Proposed Transaction have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “1933 Act“), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Tags: , , , , , , ,
Posted in Featured, Hollister Biosciences | Comments Off on Hollister Biosciences $HOLL.ca Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc. $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Datametrex $DM.ca Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 22nd, 2020
  • Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program
  • Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2
  • Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies

TORONTO, April 22, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program. Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2.  The Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies. Due to confidentiality requirements, the Company is not permitted to provide additional details about the nature of the work being performed for the Department of National Defence.

IDEaS supports the development of solutions from their conceptual stage, through prototype testing and capability development. The program includes several elements that promote collaboration between innovators, provides developmental resources and provides opportunities to interact with DND’s science and military members. Through which all innovators are on an even playing field to solve specific defence and security challenges. For more info about the program, see here: https://www.canada.ca/en/department-national-defence/programs/defence-ideas.html

“The completion of phase 2, marks the halfway point of this project and reflects the important work we are doing to help the Government of Canada maintain a technological advantage in the realm of cyber social media security. We are happy to have the go ahead to continue the contract.” says Marshall Gunter, CEO of the Company.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery or cyber security please go to: www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For more information about the IDEaS program please visit: Canada.ca/defence-ideas

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program

VIDEO: Datametrex $DM.ca Discusses Obtaining Rights to Import and Sell #COVID19 Test Kits From South Korea

Posted by AGORACOM-JC at 4:29 PM on Tuesday, April 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.  

But when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.    

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup.  But Datametrex AI (DM: TSXV) is neither.  Rather, it is a great Canadian small cap technology company who happens to have:  

“developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.”

  If that wasn’t enough, Datametrex has also achieved the following as of late:

  • Q3 Revenues Of $1.6 million,  an increase of 186%
  • 9 Month Revenues Of $2.56M an increase of 37%
  • Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE   
  • $954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
  • Participation In NATO Research Task Group On Social Media Threat Detection 
  • Becoming an affiliate member of the Carnegie Mellon University Center for IDeaS

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.  

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses obtaining the rights to import and sell COVID-19 test kits from South Korea and the impact it will have on the Company.  

Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive. 

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on VIDEO: Datametrex $DM.ca Discusses Obtaining Rights to Import and Sell #COVID19 Test Kits From South Korea

PyroGenesis $PYR.ca Receives Additional $457K Under Exclusive Agreement with US Tunneling Company $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 11:09 AM on Tuesday, April 21st, 2020
  • Announced today that, further to its press release dated April 1st, 2020, it has received an additional US$325K (approx. CA $457K) under the exclusive agreement with a US based tunneling company
  • To date, the Company has received US $725K (over CA $1M) in total

MONTREAL, April 21, 2020  — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to announce today that, further to its press release dated April 1st, 2020, it has received an additional US$325K (approx. CA $457K) under the exclusive agreement (the “Agreement”) with a US based tunneling company (the “Client”). To date, the Company has received US $725K (over CA $1M) in total. The Client’s name will remain anonymous for confidentiality and competitive reasons.

“This is an ideal contract, given the current situation, where all the engineering work can be done remotely,” said Mr. Peter Pascali, CEO of PyroGenesis Canada Inc. “This relationship is timely, given the current environment where investors are more focused on multiple secure revenue streams.  It is important to note that this relationship was not born out of the current crisis and, as such, is expected to continue well after the pandemic is behind us.”

Under this Agreement, PyroGenesis will not only develop and supply high-powered plasma torches, specifically designed for tunneling applications, but will also be intimately involved in all aspects of design and development for the entire project. Upon success, the Client is committed to purchase exclusively, and PyroGenesis is committed to exclusively supplying, plasma torches and auxiliary equipment for these applications. The scope of work is now comprised of several phases, each being defined by the results from the former.

PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods, is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.

“Once again, this Agreement underscores our plasma torch expertise, and we are pleased to be applying it to a very unique and significant opportunity,” said Mr. Alex Pascali, Business Development Manager of PyroGenesis. “This highlights the fact that we not only sell plasma torches, but also provide the expertise required to develop cutting edge plasma-based applications. The Company continues to increase revenues and reduce risk by diversifying its customer base with a standard product offering.  This is just one of many exciting developments at PyroGenesis these days.”

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]
RELATED LINK: http://www.pyrogenesis.com/

Tags: , ,
Posted in Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Receives Additional $457K Under Exclusive Agreement with US Tunneling Company $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Datametrex $DM.ca Provides Update On Health Canada Submission & Welcomes Advisors

Posted by AGORACOM-JC at 7:12 AM on Tuesday, April 21st, 2020
  • Provides additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea
  • An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020
  • As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order
  • Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada

TORONTO, April 21, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF ) wishes to provide additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea. An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020.

As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on March 18, 2020. This Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.

The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000 units, followed by an additional 100,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval. Datametrex is currently working with Dr. Lisa Palleson-Stallan and Dr. Joseph Curtis to assist with obtaining Health Canada approval, and each has agreed to join the Company’s advisory board.

Dr. Joseph Curtis is the Chief Scientific Officer and founder of BioQuant Laboratories (BQL) an independent testing laboratory providing analytical testing services to firms across the U.S. and Canada developing natural product medicines for human and animal health. Dr. Curtis has twenty-five years of experience across and has held various executive positions within public and private sector firms. Working across the public health emergency medical countermeasures continuum, he supported the USA’s blood and tissue preparedness and response programs managed by the American Red Cross. In this capacity, he served as the Director, Biomedical Headquarters Facility Quality Assurance coordinating performance excellence programs across a nation-wide network of manufacturing and testing facilities delivering $2 billion of cellular therapies and transfusion medicine products to over 3,000 hospitals across the US.

Dr. Lisa Palleson-Stallan obtained her Ph.D in International Business with Honours in the U.K. She ran a European Union funded project on technology and Innovation and completed post doctoral work at the World Health Organization (WHO) publishing on Tobacco Cessation. She created her first retail company, Lotuswear, which grew into a 100 employee + company and had the role as presidentand CEO. She became an early adopter in several industries and has continued building value from the ground up. She has built a successful consultancy company that targets the Asian marketplace within the Health space. Dr Palleson-Stallan has been given role and title of Global Health Advisor to assist the Chinese Government with unconditional support and authority to conduct negotiations regarding how to best to combat the spread of Covid-19.

“We are thrilled to be in a position to bring high quality test kits to Canada to help flatten the curve and save lives. We are doing everything we can to provide Health Canada with the required information to move forward. We are looking forward to solving these problems alongside Dr. Palleson-Stallan and Dr. Curtis.”, says Marshall Gunter, CEO of the Company.

Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

About Datametrex AI Limited

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens – Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Provides Update On Health Canada Submission & Welcomes Advisors

AGORACOM Welcomes Else Nutrition $BABY.ca – The Award Winning, Plant-Based Nutrition Company For Small Cap Investors; $10,000,000 Cash Balance For US product Launch In Q2 2020, Int’l Agreements Q3

Posted by AGORACOM-JC at 8:30 AM on Monday, April 20th, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

baby-100

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 
nutrition
BABY-screen1

LEARN MORE!

Hub On AGORACOM / Corporate Profile

Tags: , , , , , ,
Posted in AGORACOM Clients (New), All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on AGORACOM Welcomes Else Nutrition $BABY.ca – The Award Winning, Plant-Based Nutrition Company For Small Cap Investors; $10,000,000 Cash Balance For US product Launch In Q2 2020, Int’l Agreements Q3

REMINDER: You’re Invited – KABN Systems North America Online “Ask Me Anything” Event Today at 12pm EST

Posted by AGORACOM-JC at 9:14 AM on Friday, April 17th, 2020

KABN Systems North America is in the business of verifying, managing and monetizing online Digital Identity.We’re inviting you to join our online “Ask Me Anything” event with the KABN Systems North America Team

Join Us:

Today from 12pm to 1pm Eastern

Digital Data is the new “Gold”!

KABN North America empowers users to verify, protect, manage and profit from their Digital Identity.  With the recent changes to working, shopping, educating and playing from home, online usage and engagement is growing.

KABN’s business is:

  • About providing consumers with no-cost tools to manage their Digital Identity and profit from the public data.
  • Focused online making us Covid-19 resistant.
  • Relevant to 100% of the online, digital market.
  • Optimized for commercial partnerships in Financial Services, eCommerce, Education, Government, Healthcare, Technology, Gaming & more.
  • Built, scalable, proven and in market today.
  • Aligned with online revenue trends.
  • Run by a veteran team of successful industry leaders.
  • In process of a proposed RTO transaction for public listing.

KABN Systems North America Inc.

www.kabnsystemsna.com

Tags: , , , , ,
Posted in Featured, KABN | Comments Off on REMINDER: You’re Invited – KABN Systems North America Online “Ask Me Anything” Event Today at 12pm EST

Eyecarrot $EYC.ca Sports Vision Partnership with Eli Wilson Goaltending Redefines How 50,000 Aspiring Goalies See the Game

Posted by AGORACOM-JC at 7:17 AM on Friday, April 17th, 2020
Eyecarrot | LinkedIn
  • Announced a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics
  • Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada

Toronto, New York -  April 17th, 2020 – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR) is excited to announce a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics. Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada. The partnership will provide Eli Wilson Goaltending camps with the Binovi Touch neurovision sports training hardware, alongside screen-based resources for athletes to support their development on and off the ice. The Eli Wilson Goaltending partnership will ultimately expose 600 active goaltending camp participants, aged 10 to 19 years and a global network of over 50,000 aspiring goaltending athletes to Eyecarrot’s Binovi Sport Vision Platform for off-ice training. As many nations continue to practice social distancing during COVID-19 and post pandemic, the Binovi Sports Vision Platform offers accessible turnkey athletic resources in step with subscription-based home fitness solutions Tonal, Peloton (PTON: NASDAQ) and Mirror. A subscription structure will support the company’s global product scaling strategy and “at-home” consumer offerings.

“I emphatically believe the best way to develop goaltenders is by teaching a system within a system. Quality drills, attention to detail, repetition and simplicity are major factors in building successful goaltenders. The goaltender must learn needed skills in a progressive manner in a controlled environment. With Binovi, we are gaining a sports vision training system to improve vision in that same controlled way, ensuring proper analysis and progress,” commented Eli Wilson, Eli Wilson Goaltending Founder, CEO

Under his tutelage, Eli’s camps –which see over 600 athletes annually– have produced more than 50 NHL draft picks, over 60 Division I, Canadian University goaltenders, and more than 200 players drafted by Major Junior teams. His goaltenders have gone on to win numerous prestigious awards and championships, including the Stanley Cup, Conn Smythe Trophy, Vezina Trophy, World Junior Gold Medals, American Hockey League (AHL) championships, AHL Playoff MVPs, Western Hockey League (WHL) Goaltender of the Year awards, Ontario Hockey League (OHL) Goaltender of the Year awards, and Canadian Hockey League (CHL) Goaltender of the Year awards. In addition to standard camp programming, Eli has introduced a number of specialty camps, including the popular 24/7 camp, where goaltenders actually live and train with Eli over a three-day weekend. A main staple of Eli’s year-round training is advanced video technology, whereby he and his staff can analyze video remotely to further goaltending development.

This strategic partnership will support Eyecarrot’s aggressive positioning of its sports vision performance offerings in the sport of hockey through an increased presence in key hockey development programs including direct NHL team alignments. Hockey, a leading sport in Canada, will benefit from big-tech partnerships of this nature that are designed to enhance athlete performance at all development levels of the sport.

“We’re very excited to be working with an athletic training team that clearly has a very high drive for success, and such an incredible track record for turning out exceptional players. Our goal is to see Binovi boost the performance of athletes going through these camps and training regimens. After all, competition is what drives sport, and any edge players and their training teams can get to get that competitive edge over an opponent is key. We look forward to working alongside Eli and his team as we continue to develop Binovi for sports,” stated Adam Cegielski, President and CEO.

Click here for more information on Binovi Sports Vision Training.

About Eli Wilson Goaltending

Eli Wilson has worked with over 30 NHL goalies (and counting) to sharpen all essential goaltending skills, including mental conditioning and off-ice training. Eli’s programs help to hone an athlete’s reflexes and improve agility in the net. The camp experience mirrors how Pro and NHL goaltenders’ practice, train, think, and act, to get to the top of their game. In 2004, Eli was named to Hockey Canada’s goaltending consultant group. He has consulted with Creative Artists Agency (CAA) Sports during their summer development camps for top young prospects in Los Angeles, California. Eli has also traveled to South Korea to work with the Kangwon Land Ice Hockey team and other young goaltenders in the country. From 2007 through 2010, Eli was the goaltending coach for the Ottawa Senators, where he was responsible for the Ottawa Senators goaltenders as well as for the goalies playing for their AHL affiliate, the Binghamton Senators. Established in 2010, the Eli Wilson Goaltending program sees over 600 athletes every year and helps give them the competitive edge to set themselves apart in a very challenging and exclusive club.

About the NHL

The National Hockey League (NHL(R)), founded in 1917, consists of 31 Member Clubs, each reflecting the League’s international makeup with players from more than 20 countries represented on team rosters, vying for the most cherished and historic trophy in professional sports – the Stanley Cup(R). Every year, the NHL entertains more than 670 million fans in-arena and through its partners on national television and radio; more than 151 million followers – league, team and player accounts combined – across Facebook, Twitter, Instagram, Snapchat and YouTube; and more than 100 million fans online at NHL.com. The League broadcasts games in more than 160 countries and territories through its rightsholders including NBC/NBCSN and the NHL Network(TM) in the U.S., Sportsnet and TVA in Canada, Viasat in the Nordic Region and CCTV and Tencent in China. The NHL reaches fans worldwide with games available online in every country including via its live and on-demand streaming service NHL.TV(TM). Fans are engaged across the League’s digital assets on mobile devices via the free NHL(R) App; across nine social media platforms; on SiriusXM NHL Network Radio(TM); and on NHL.com, available in eight languages and featuring unprecedented access to player and team statistics as well as every regular-season and playoff game box score dating back to the League’s inception, powered by SAP. The NHL is committed to building healthy and vibrant communities through the sport of hockey by increasing youth participation and engagement; fostering positive family experiences; promoting inclusion, positive culture and leadership; and supporting sustainable community impact.

About Eyecarrot Innovations Corp

Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Adam Cegielski

President | CEO

Tania Archer

Head of Global Marketing | Sales | Strategic Partnerships

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , ,
Posted in Eyecarrot Innovations Corp, Featured | Comments Off on Eyecarrot $EYC.ca Sports Vision Partnership with Eli Wilson Goaltending Redefines How 50,000 Aspiring Goalies See the Game

Datametrex $DM.ca Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea

Posted by AGORACOM-JC at 7:15 AM on Thursday, April 16th, 2020
  • Entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada
  • Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States
  • iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy

TORONTO, April 16, 2020  — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to announce that entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada, Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States. Datametrex has developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.

The COVID-19 test kits are manufactured by iONEBIO INC. in South Korea, and are the same test kits that have been successfully used in South Korea in their “drive-through” testing stations. This kit has also been used to test every traveller entering into South Korea and those testing positive for Covid-19 were immediately isolated.  Datametrex believes a key factor that allowed South Korea to slow the spread of COVID-19 was its ability to swiftly identify and quarantine those infected by testing millions of people using these test kits  These test kits were first approved for use by the Korean Ministry of Food and Drug Safety on August 30, 2019.  In addition, an independent study was conducted by DankukUniversity (DKU) in Seoul, South Korea, and it was completed and approved on April 2, 2020.

Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company is currently working with Health Canada to have the approval of these kits fast tracked.  These test kits are currently in use in some European and Asian countries outside of South Korea. Approval work has commenced with the FDA in the United States to obtain FDA approval and to authorize the tests under the Emergency Use Authorization Program run by US Center for Disease Control (CDC).

iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour. By utilizing these kits, screening stations can be set up almost anywhere and will allow for the early detection and swift quarantine of infected persons, which is believed to be a key factor in slowing the spread of the novel coronavirus.  Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

South Korea has used this kit to test millions of its citizens and, as of April 14, 2020, there have been 10,654 cases of Covid-19 and 222 deaths reported. In North America, where the use of a rapid test has not been implemented on a large scale, there have been, as at April 14, 2020, 25,680 cases and 780 deaths in Canada and 588,465 cases and 23,711 death in the US.  (All data collected by Datametrex’s Covid-19 dashboard, which is available at http://www.datametrex.com/covid-board.html)

“We strongly believe these kits will assist Canada in slowing the spread of Covid-19 and ultimately save lives. It’s incredibly rewarding for us to be able to help Canada combat the spread of COVID-19,” said Andrew Ryu, Chairman of the Company.

If the test kits are approved by Health Canada and the Canadian government purchases these test kits as expected, the Canadian government will be required to pay the kits in advance. Datametrex expects that all of its costs and expenses related to the import of these tests will be satisfied out of the purchase price for the tests paid for by the Canadian government.

The Company is not making any express or implied claims that it has the ability to treat the Covid-19 virus at this time.

About Datametrex AI Limited

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea

« Older Entries
Newer Entries »